Seyfarth's Intellectual Property Practice Group is delighted to announce the launch of BioLoquitur on LexBlog. Seyfarth's IP-life sciences attorneys created this blog as a single resource for executives and corporate in-house counsel seeking timely updates on recent developments, trends, tools, best practices, and discussions in the area of intellectual property—patent law, particularly in the life sciences industry.
The BioLoquitur blog offers an all-inclusive assessment of the law regarding life sciences, including issues related to Hatch-Waxman litigation, patentability and patent eligibility, biosimilars, freedom to operate, patent enforcement, America Invents Act (AIA) proceedings, and patent prosecution.
Our team of bloggers have a deep understanding of the biotechnology, chemical, pharmaceutical, and nanotechnology industries. Our attorneys have handled all aspects of life sciences-related intellectual property, including patent litigation, prosecution, due diligence, counseling, and transactions. Our broad technical training, as well as years of legal experience representing clients in court before the United States Patent and Trademark Office as venture capitalists and in-house counsel, allow our attorneys to work closely with clients to not only understand but achieve their technical, business, and legal goals.
If you would like to receive our BioLoquitur blog updates via email as soon as they are published, please subscribe by clicking here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.